Literature DB >> 26311408

Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.

Luigi Yuri Di Marco1, Annalena Venneri2, Eszter Farkas3, Paul C Evans4, Alberto Marzo5, Alejandro F Frangi6.   

Abstract

Late-onset dementia is a major health concern in the ageing population. Alzheimer's disease (AD) accounts for the largest proportion (65-70%) of dementia cases in the older population. Despite considerable research effort, the pathogenesis of late-onset AD remains unclear. Substantial evidence suggests that the neurodegenerative process is initiated by chronic cerebral hypoperfusion (CCH) caused by ageing and cardiovascular conditions. CCH causes reduced oxygen, glucose and other nutrient supply to the brain, with direct damage not only to the parenchymal cells, but also to the blood-brain barrier (BBB), a key mediator of cerebral homeostasis. BBB dysfunction mediates the indirect neurotoxic effects of CCH by promoting oxidative stress, inflammation, paracellular permeability, and dysregulation of nitric oxide, a key regulator of regional blood flow. As such, BBB dysfunction mediates a vicious circle in which cerebral perfusion is reduced further and the neurodegenerative process is accelerated. Endothelial interaction with pericytes and astrocytes could also play a role in the process. Reciprocal interactions between vascular dysfunction and neurodegeneration could further contribute to the development of the disease. A comprehensive overview of the complex scenario of interacting endothelium-mediated processes is currently lacking, and could prospectively contribute to the identification of adequate therapeutic interventions. This study reviews the current literature of in vitro and ex vivo studies on endothelium-mediated mechanisms underlying vascular dysfunction in AD pathogenesis, with the aim of presenting a comprehensive overview of the complex network of causative relationships. Particular emphasis is given to vicious circles which can accelerate the process of neurovascular degeneration.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; Blood–brain barrier permeability; Cerebral hypoperfusion; Endothelial dysfunction; Mitochondrial dysfunction; Ultrastructural damage

Mesh:

Year:  2015        PMID: 26311408     DOI: 10.1016/j.nbd.2015.08.014

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  84 in total

1.  Perforin Promotes Amyloid Beta Internalisation in Neurons.

Authors:  Erica Lana; Mahbod Khanbolouki; Charline Degavre; Eva-Britt Samuelsson; Elisabet Åkesson; Bengt Winblad; Evren Alici; Christina Unger Lithner; Homira Behbahani
Journal:  Mol Neurobiol       Date:  2016-01-16       Impact factor: 5.590

Review 2.  An endothelial link between the benefits of physical exercise in dementia.

Authors:  Lianne J Trigiani; Edith Hamel
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-15       Impact factor: 6.200

Review 3.  Linking multiple pathogenic pathways in Alzheimer's disease.

Authors:  Rami Bou Khalil; Elie Khoury; Salam Koussa
Journal:  World J Psychiatry       Date:  2016-06-22

Review 4.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

5.  Pulsatility and high shear stress deteriorate barrier phenotype in brain microvascular endothelium.

Authors:  Fernando Garcia-Polite; Jordi Martorell; Paula Del Rey-Puech; Pedro Melgar-Lesmes; Caroline C O'Brien; Jaume Roquer; Angel Ois; Alessandro Principe; Elazer R Edelman; Mercedes Balcells
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

6.  Microvascular Endothelial Function and Neurocognition Among Adults With Major Depressive Disorder.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Lana L Watkins; Benson M Hoffman; Andrew Sherwood
Journal:  Am J Geriatr Psychiatry       Date:  2018-06-28       Impact factor: 4.105

Review 7.  Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association.

Authors:  Costantino Iadecola; Kristine Yaffe; José Biller; Lisa C Bratzke; Frank M Faraci; Philip B Gorelick; Martha Gulati; Hooman Kamel; David S Knopman; Lenore J Launer; Jane S Saczynski; Sudha Seshadri; Adina Zeki Al Hazzouri
Journal:  Hypertension       Date:  2016-10-10       Impact factor: 10.190

8.  Neurovascular Organotypic Culture Models Using Induced Pluripotent Stem Cells to Assess Adverse Chemical Exposure Outcomes.

Authors:  Eric H Nguyen; Micah J Dombroe; Debra L Fisk; William T Daly; Christine M Sorenson; William L Murphy; Nader Sheibani
Journal:  Appl In Vitro Toxicol       Date:  2019-06-17

9.  Association of Preclinical Alzheimer Disease With Optical Coherence Tomographic Angiography Findings.

Authors:  Bliss Elizabeth O'Bryhim; Rajendra S Apte; Nathan Kung; Dean Coble; Gregory P Van Stavern
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

10.  Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease.

Authors:  Anna Csiszar; Stefano Tarantini; Gábor A Fülöp; Tamas Kiss; M Noa Valcarcel-Ares; Veronica Galvan; Zoltan Ungvari; Andriy Yabluchanskiy
Journal:  Geroscience       Date:  2017-08-29       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.